Chiral molecules are crucial in the pharmaceutical industry. Chiral synthesis, also known as enantioselective or asymmetric synthesis, is the process of creating compounds in a way that favors the formation of a specific enantiomer or diastereomer. This process is fundamental in modern chemistry, especially in medicinal chemistry, as different enantiomers or diastereomers of a molecule often exhibit distinct biological activities. At Orbiton, our team of experts brings extensive experience in diastereoselective and enantioselective synthesis on a large scale. Our R&D scientists stay up-to-date with the latest advancements in asymmetric synthesis to identify the most efficient synthetic routes that yield pure enantiomers.
Partner with us to overcome your R&D challenges and accelerate your next discoveries faster. We can be a trusted extension of your R&D team and help solve complex chemistry and innovative challenges in a cost-effective manner and within a short turnaround time.
Call us today to find out how a chemistry CRO can help you. You can call us directly at +91 9384980267 or fill out the form below; a team member will review your message and get in touch with you.
